Natural Investments’s Calvert Ultra-Short Investment Grade ETF CVSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$569K Buy
11,242
+1,165
+12% +$59.1K 0.13% 144
2026
Q1
$509K Sell
10,077
-89
-0.9% -$4.52K 0.13% 157
2025
Q4
$515K Buy
+10,166
New +$516K 0.13% 154
2025
Q3
Sell
-9,177
Closed -$464K 247
2025
Q2
$464K Buy
9,177
+134
+1% +$6.79K 0.12% 148
2025
Q1
$457K Sell
9,043
-17
-0.2% -$863 0.13% 141
2024
Q4
$459K Buy
+9,060
New +$460K 0.13% 146

Other funds holding CVSB

Natural Investments's CVSB Position: Q2 2026 in Review

Natural Investments increased its Calvert Ultra-Short Investment Grade ETF (CVSB) stake by 12% in Q2 2026, buying an estimated $59.1K and bringing the position to 11,242 shares worth $569K. The position accounts for 0.13% of the portfolio, ranked #144.

Natural Investments first reported a position in CVSB in Q4 2024 and has held it in 6 quarters since. 18 funds tracked by Wall St. Rank hold CVSB as of Q2 2026.

  • Natural Investments held 11,242 shares of Calvert Ultra-Short Investment Grade ETF worth $569K as of Q2 2026.
  • Natural Investments bought 1,165 Calvert Ultra-Short Investment Grade ETF shares in Q2 2026, an estimated $59.1K.
  • Calvert Ultra-Short Investment Grade ETF made up 0.13% of Natural Investments's portfolio in Q2 2026, its #144 holding.
  • Natural Investments first reported a position in Calvert Ultra-Short Investment Grade ETF in Q4 2024 and has held it in 6 quarters since.
  • 18 funds tracked by Wall St. Rank held Calvert Ultra-Short Investment Grade ETF as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.